JCriticalCare Profile Banner
JCriticalCare Profile
JCriticalCare

@JCriticalCare

Followers
943
Following
233
Media
54
Statuses
206

The Journal of Critical Care is a leading international, peer-reviewed journal that aims to improve patient care integrating science and clinical practice.

New York/ Netherlands
Joined January 2020
Don't wanna be here? Send us removal request.
@JCriticalCare
JCriticalCare
2 months
Insights from the HYPO-ECMO trial.
0
1
2
@JCriticalCare
JCriticalCare
3 months
What Every Intensivist Should Know About Medullary Renal Perfusion .
Tweet media one
Tweet media two
0
3
18
@JCriticalCare
JCriticalCare
3 months
RT @msiuba: New 📝: Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review
Tweet media one
Tweet media two
0
50
0
@JCriticalCare
JCriticalCare
3 months
RT @msiuba: Hey it’s our paper! Check it out if you prescribe terlipressin….
0
7
0
@JCriticalCare
JCriticalCare
3 months
Understanding ventilator-induced lung injury: The role of mechanical power.Great paper!.
Tweet media one
0
3
11
@JCriticalCare
JCriticalCare
3 months
Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review.
Tweet media one
0
5
10
@JCriticalCare
JCriticalCare
4 months
This is the largest randomised control trial studying microcirculation in and fluid bolus! Check it out 🔥.
Tweet media one
0
0
0
@JCriticalCare
JCriticalCare
5 months
💡 Key Insights:.- Identified key factors associated with increased mortality, highlighting the critical role of epinephrine use. - Demonstrated significantly worse outcomes in this vulnerable patient population compared to those without cancer.
Tweet media one
0
1
1
@JCriticalCare
JCriticalCare
5 months
Early high-dose vasopressors in refractory septic shock seems associated with reduced mortality and more days alive and free from organ-support therapies. Great paper!.
Tweet media one
0
2
1
@JCriticalCare
JCriticalCare
5 months
RT @alebelletti1: 2/.➡️See the full results of the #CHEETAH RCT on @NEJM: ➡️And 1-year follow-up results on @JCrit….
0
3
0
@JCriticalCare
JCriticalCare
6 months
Great paper by @a_serpaneto et al. Mild hypercapnia does not increase adverse renal events and has a limited effect on pH!.
0
1
4
@JCriticalCare
JCriticalCare
6 months
🧠 Ventilator-Associated Pneumonia in TBI Patients: A Systematic Review & Meta-Analysis.Key findings: Severe head injury, blood transfusion, and barbiturate use linked to higher VAP risk, while prophylactic antibiotics and younger age were protective. 🔗
0
0
1
@JCriticalCare
JCriticalCare
6 months
📢 New in Journal of Critical Care!. 💧 Fluid Management in Adult Patients Undergoing VA-ECMO: A Scoping Review. Explores optimal fluid strategies in critically ill patients receiving VA-ECMO support. 🔗 Read more: . #CriticalCare #ECMO #MedTwitter.
0
0
2
@JCriticalCare
JCriticalCare
7 months
Indications, results and consequences of electroencephalography in neurocritical care.
0
0
0
@JCriticalCare
JCriticalCare
7 months
From our arquives . Long term feasibility of ultraprotective lung ventilation with low-flow extracorporeal carbon dioxide removal in ARDS patients. #gattinoni.
0
0
0
@JCriticalCare
JCriticalCare
7 months
In memory of Prof Luciano Gattinoni, towering figure in Critical Care, profoundly shaping understanding of #ARDS & #ECMO. The “father" of prone position revolutionized MV with a pioneering "baby lung” concept. His legacy will guide/inspire for generations to come. RIP
Tweet media one
2
32
141
@JCriticalCare
JCriticalCare
7 months
A Legend in critical care! RIP Professor Gattinoni.
@iceman_ex
Segun Olusanya (He/Him) [email protected]
7 months
0
0
3
@JCriticalCare
JCriticalCare
7 months
Challenges and opportunities in antibiotic allergy de-labeling in intensive care units: The time is now!.
Tweet media one
0
0
3
@JCriticalCare
JCriticalCare
7 months
This model is particularly valuable in settings without access to specialized allergy services, enhancing care quality and addressing antimicrobial resistance. So check it out the full paper! 🔥.
0
0
0
@JCriticalCare
JCriticalCare
7 months
An ICU-led approach to antibiotic allergy assessment and de-labeling is safe, feasible, and improves antimicrobial stewardship by enabling the use of first-line antibiotics while reducing reliance on broad-spectrum therapies.
1
0
0